APO Research
Talk to an analyst

APO RESEARCH · REPORT

Quetiapine Fumarate Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Quetiapine Fumarate Tablets Market Outlook and Growth Opportunities 2026

29 December 2025194 pages

Choose your research edition.

Industry ResearchQuetiapine Fumarate Tablets Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Quetiapine Fumarate Tablets Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Quetiapine Fumarate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Quetiapine Fumarate Tablets Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Quetiapine Fumarate Tablets Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Quetiapine Fumarate Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Quetiapine Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Quetiapine Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Quetiapine Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Quetiapine Fumarate Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Quetiapine Fumarate Tablets market include Teva Pharmaceuticals, Sun Pharma, Sandoz, Lupin Limited, Hunan Dongting Pharmaceutical, Hikma, Dr. Reddy's Laboratories, AstraZeneca and Alkem Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Quetiapine Fumarate Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Quetiapine Fumarate Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Quetiapine Fumarate Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Quetiapine Fumarate Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Quetiapine Fumarate Tablets Segment by Company

Teva Pharmaceuticals

Sun Pharma

Sandoz

Lupin Limited

Hunan Dongting Pharmaceutical

Hikma

Dr. Reddy's Laboratories

AstraZeneca

Alkem Laboratories

Quetiapine Fumarate Tablets Segment by Type

0.2g

0.3g

Others

Quetiapine Fumarate Tablets Segment by Application

Hospital

Clinic

Others

Quetiapine Fumarate Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Quetiapine Fumarate Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Quetiapine Fumarate Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Quetiapine Fumarate Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Quetiapine Fumarate Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quetiapine Fumarate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Quetiapine Fumarate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quetiapine Fumarate Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Quetiapine Fumarate Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Quetiapine Fumarate Tablets industry.

Chapter 3: Detailed analysis of Quetiapine Fumarate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Quetiapine Fumarate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Quetiapine Fumarate Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Quetiapine Fumarate Tablets Industry Trends Table 2. Quetiapine Fumarate Tablets Industry Drivers Table 3. Quetiapine Fumarate Tablets Industry Opportunities and Challenges Table 4. Quetiapine Fumarate Tablets Industry Restraints Table 5. Global Quetiapine Fumarate Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Quetiapine Fumarate Tablets Revenue Share by Company (2021-2026) Table 7. Global Quetiapine Fumarate Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Quetiapine Fumarate Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Quetiapine Fumarate Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Quetiapine Fumarate Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Quetiapine Fumarate Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Quetiapine Fumarate Tablets Company, Product Type & Application Table 13. Global Quetiapine Fumarate Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Quetiapine Fumarate Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 0.2g Table 18. Significant Companies of 0.3g Table 19. Significant Companies of Others Table 20. Global Quetiapine Fumarate Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Quetiapine Fumarate Tablets Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Quetiapine Fumarate Tablets Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Quetiapine Fumarate Tablets Sales Volume Share by Type (2021-2026) Table 24. Global Quetiapine Fumarate Tablets Sales Volume Share by Type (2027-2032) Table 25. Global Quetiapine Fumarate Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Quetiapine Fumarate Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Quetiapine Fumarate Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Quetiapine Fumarate Tablets Sales Value Share by Type (2021-2026) Table 29. Global Quetiapine Fumarate Tablets Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Significant Companies of Others Table 33. Global Quetiapine Fumarate Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Quetiapine Fumarate Tablets Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Quetiapine Fumarate Tablets Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Quetiapine Fumarate Tablets Sales Volume Share by Application (2021-2026) Table 37. Global Quetiapine Fumarate Tablets Sales Volume Share by Application (2027-2032) Table 38. Global Quetiapine Fumarate Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Quetiapine Fumarate Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Quetiapine Fumarate Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Quetiapine Fumarate Tablets Sales Value Share by Application (2021-2026) Table 42. Global Quetiapine Fumarate Tablets Sales Value Share by Application (2027-2032) Table 43. Global Quetiapine Fumarate Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Quetiapine Fumarate Tablets Sales by Region (2021-2026) & (K Units) Table 45. Global Quetiapine Fumarate Tablets Sales Market Share by Region (2021-2026) Table 46. Global Quetiapine Fumarate Tablets Sales by Region (2027-2032) & (K Units) Table 47. Global Quetiapine Fumarate Tablets Sales Market Share by Region (2027-2032) Table 48. Global Quetiapine Fumarate Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Quetiapine Fumarate Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Quetiapine Fumarate Tablets Sales Value Share by Region (2021-2026) Table 51. Global Quetiapine Fumarate Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Quetiapine Fumarate Tablets Sales Value Share by Region (2027-2032) Table 53. Global Quetiapine Fumarate Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Quetiapine Fumarate Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Quetiapine Fumarate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Quetiapine Fumarate Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Quetiapine Fumarate Tablets Sales by Country (2021-2026) & (K Units) Table 58. Global Quetiapine Fumarate Tablets Sales Market Share by Country (2021-2026) Table 59. Global Quetiapine Fumarate Tablets Sales by Country (2027-2032) & (K Units) Table 60. Global Quetiapine Fumarate Tablets Sales Market Share by Country (2027-2032) Table 61. Global Quetiapine Fumarate Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Quetiapine Fumarate Tablets Sales Value Market Share by Country (2021-2026) Table 63. Global Quetiapine Fumarate Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Quetiapine Fumarate Tablets Sales Value Market Share by Country (2027-2032) Table 65. Teva Pharmaceuticals Company Information Table 66. Teva Pharmaceuticals Business Overview Table 67. Teva Pharmaceuticals Quetiapine Fumarate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Teva Pharmaceuticals Quetiapine Fumarate Tablets Product Portfolio Table 69. Teva Pharmaceuticals Recent Development Table 70. Sun Pharma Company Information Table 71. Sun Pharma Business Overview Table 72. Sun Pharma Quetiapine Fumarate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Sun Pharma Quetiapine Fumarate Tablets Product Portfolio Table 74. Sun Pharma Recent Development Table 75. Sandoz Company Information Table 76. Sandoz Business Overview Table 77. Sandoz Quetiapine Fumarate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Sandoz Quetiapine Fumarate Tablets Product Portfolio Table 79. Sandoz Recent Development Table 80. Lupin Limited Company Information Table 81. Lupin Limited Business Overview Table 82. Lupin Limited Quetiapine Fumarate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Lupin Limited Quetiapine Fumarate Tablets Product Portfolio Table 84. Lupin Limited Recent Development Table 85. Hunan Dongting Pharmaceutical Company Information Table 86. Hunan Dongting Pharmaceutical Business Overview Table 87. Hunan Dongting Pharmaceutical Quetiapine Fumarate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Hunan Dongting Pharmaceutical Quetiapine Fumarate Tablets Product Portfolio Table 89. Hunan Dongting Pharmaceutical Recent Development Table 90. Hikma Company Information Table 91. Hikma Business Overview Table 92. Hikma Quetiapine Fumarate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Hikma Quetiapine Fumarate Tablets Product Portfolio Table 94. Hikma Recent Development Table 95. Dr. Reddy's Laboratories Company Information Table 96. Dr. Reddy's Laboratories Business Overview Table 97. Dr. Reddy's Laboratories Quetiapine Fumarate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Dr. Reddy's Laboratories Quetiapine Fumarate Tablets Product Portfolio Table 99. Dr. Reddy's Laboratories Recent Development Table 100. AstraZeneca Company Information Table 101. AstraZeneca Business Overview Table 102. AstraZeneca Quetiapine Fumarate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. AstraZeneca Quetiapine Fumarate Tablets Product Portfolio Table 104. AstraZeneca Recent Development Table 105. Alkem Laboratories Company Information Table 106. Alkem Laboratories Business Overview Table 107. Alkem Laboratories Quetiapine Fumarate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Alkem Laboratories Quetiapine Fumarate Tablets Product Portfolio Table 109. Alkem Laboratories Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Quetiapine Fumarate Tablets Distributors List Table 113. Quetiapine Fumarate Tablets Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Quetiapine Fumarate Tablets Product Image Figure 2. Global Quetiapine Fumarate Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Quetiapine Fumarate Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Quetiapine Fumarate Tablets Sales (2021-2032) & (K Units) Figure 5. Global Quetiapine Fumarate Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Quetiapine Fumarate Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 0.2g Image Figure 10. 0.3g Image Figure 11. Others Image Figure 12. Global Quetiapine Fumarate Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Quetiapine Fumarate Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Quetiapine Fumarate Tablets Sales Volume Share by Type (2021-2032) Figure 15. Global Quetiapine Fumarate Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Quetiapine Fumarate Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Quetiapine Fumarate Tablets Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Others Image Figure 21. Global Quetiapine Fumarate Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Quetiapine Fumarate Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Quetiapine Fumarate Tablets Sales Volume Share by Application (2021-2032) Figure 24. Global Quetiapine Fumarate Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Quetiapine Fumarate Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Quetiapine Fumarate Tablets Sales Value Share by Application (2021-2032) Figure 27. Global Quetiapine Fumarate Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Quetiapine Fumarate Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Quetiapine Fumarate Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Quetiapine Fumarate Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Quetiapine Fumarate Tablets Sales Value (2021-2032) & (US$ Million) Figure 32. North America Quetiapine Fumarate Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Quetiapine Fumarate Tablets Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Quetiapine Fumarate Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Quetiapine Fumarate Tablets Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Quetiapine Fumarate Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Quetiapine Fumarate Tablets Sales Value (2021-2032) & (US$ Million) Figure 38. South America Quetiapine Fumarate Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Quetiapine Fumarate Tablets Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Quetiapine Fumarate Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Quetiapine Fumarate Tablets Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Quetiapine Fumarate Tablets Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 0.2g
  • 0.3g
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva Pharmaceuticals
  • Sun Pharma
  • Sandoz
  • Lupin Limited
  • Hunan Dongting Pharmaceutical
  • Hikma
  • Dr. Reddy's Laboratories
  • AstraZeneca
  • Alkem Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Quetiapine Fumarate Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Quetiapine Fumarate Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Quetiapine Fumarate Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Quetiapine Fumarate Tablets Market Dynamics
  1. 2.1 Quetiapine Fumarate Tablets Industry Trends
  2. 2.2 Quetiapine Fumarate Tablets Industry Drivers
  3. 2.3 Quetiapine Fumarate Tablets Industry Opportunities and Challenges
  4. 2.4 Quetiapine Fumarate Tablets Industry Restraints
3 Quetiapine Fumarate Tablets Market by Company
  1. 3.1 Global Quetiapine Fumarate Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Quetiapine Fumarate Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Quetiapine Fumarate Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Quetiapine Fumarate Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Quetiapine Fumarate Tablets Company Ranking (2024-2026)
  6. 3.6 Global Quetiapine Fumarate Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Quetiapine Fumarate Tablets Company Product Type and Application
  8. 3.8 Global Quetiapine Fumarate Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Quetiapine Fumarate Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Quetiapine Fumarate Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Quetiapine Fumarate Tablets Market by Type
  1. 4.1 Quetiapine Fumarate Tablets Type Introduction
  2. 4.1.1 0.2g
  3. 4.1.2 0.3g
  4. 4.1.3 Others
  5. 4.2 Global Quetiapine Fumarate Tablets Sales Volume by Type
  6. 4.2.1 Global Quetiapine Fumarate Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Quetiapine Fumarate Tablets Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Quetiapine Fumarate Tablets Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Quetiapine Fumarate Tablets Sales Value by Type
  10. 4.3.1 Global Quetiapine Fumarate Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Quetiapine Fumarate Tablets Sales Value by Type (2021-2032)
  12. 4.3.3 Global Quetiapine Fumarate Tablets Sales Value Share by Type (2021-2032)
5 Quetiapine Fumarate Tablets Market by Application
  1. 5.1 Quetiapine Fumarate Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Quetiapine Fumarate Tablets Sales Volume by Application
  6. 5.2.1 Global Quetiapine Fumarate Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Quetiapine Fumarate Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Quetiapine Fumarate Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Quetiapine Fumarate Tablets Sales Value by Application
  10. 5.3.1 Global Quetiapine Fumarate Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Quetiapine Fumarate Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Quetiapine Fumarate Tablets Sales Value Share by Application (2021-2032)
6 Quetiapine Fumarate Tablets Regional Sales and Value Analysis
  1. 6.1 Global Quetiapine Fumarate Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Quetiapine Fumarate Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Quetiapine Fumarate Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Quetiapine Fumarate Tablets Sales by Region (2027-2032)
  5. 6.3 Global Quetiapine Fumarate Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Quetiapine Fumarate Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Quetiapine Fumarate Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Quetiapine Fumarate Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Quetiapine Fumarate Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Quetiapine Fumarate Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Quetiapine Fumarate Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Quetiapine Fumarate Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Quetiapine Fumarate Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Quetiapine Fumarate Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Quetiapine Fumarate Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Quetiapine Fumarate Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Quetiapine Fumarate Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Quetiapine Fumarate Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Quetiapine Fumarate Tablets Sales Value Share by Country, 2025 VS 2032
7 Quetiapine Fumarate Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Quetiapine Fumarate Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Quetiapine Fumarate Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Quetiapine Fumarate Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Quetiapine Fumarate Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Quetiapine Fumarate Tablets Sales by Country (2027-2032)
  6. 7.4 Global Quetiapine Fumarate Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Quetiapine Fumarate Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Quetiapine Fumarate Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Quetiapine Fumarate Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Quetiapine Fumarate Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Quetiapine Fumarate Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceuticals
  2. 8.1.1 Teva Pharmaceuticals Company Information
  3. 8.1.2 Teva Pharmaceuticals Business Overview
  4. 8.1.3 Teva Pharmaceuticals Quetiapine Fumarate Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceuticals Quetiapine Fumarate Tablets Product Portfolio
  6. 8.1.5 Teva Pharmaceuticals Recent Developments
  7. 8.2 Sun Pharma
  8. 8.2.1 Sun Pharma Company Information
  9. 8.2.2 Sun Pharma Business Overview
  10. 8.2.3 Sun Pharma Quetiapine Fumarate Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharma Quetiapine Fumarate Tablets Product Portfolio
  12. 8.2.5 Sun Pharma Recent Developments
  13. 8.3 Sandoz
  14. 8.3.1 Sandoz Company Information
  15. 8.3.2 Sandoz Business Overview
  16. 8.3.3 Sandoz Quetiapine Fumarate Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sandoz Quetiapine Fumarate Tablets Product Portfolio
  18. 8.3.5 Sandoz Recent Developments
  19. 8.4 Lupin Limited
  20. 8.4.1 Lupin Limited Company Information
  21. 8.4.2 Lupin Limited Business Overview
  22. 8.4.3 Lupin Limited Quetiapine Fumarate Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Lupin Limited Quetiapine Fumarate Tablets Product Portfolio
  24. 8.4.5 Lupin Limited Recent Developments
  25. 8.5 Hunan Dongting Pharmaceutical
  26. 8.5.1 Hunan Dongting Pharmaceutical Company Information
  27. 8.5.2 Hunan Dongting Pharmaceutical Business Overview
  28. 8.5.3 Hunan Dongting Pharmaceutical Quetiapine Fumarate Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hunan Dongting Pharmaceutical Quetiapine Fumarate Tablets Product Portfolio
  30. 8.5.5 Hunan Dongting Pharmaceutical Recent Developments
  31. 8.6 Hikma
  32. 8.6.1 Hikma Company Information
  33. 8.6.2 Hikma Business Overview
  34. 8.6.3 Hikma Quetiapine Fumarate Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hikma Quetiapine Fumarate Tablets Product Portfolio
  36. 8.6.5 Hikma Recent Developments
  37. 8.7 Dr. Reddy's Laboratories
  38. 8.7.1 Dr. Reddy's Laboratories Company Information
  39. 8.7.2 Dr. Reddy's Laboratories Business Overview
  40. 8.7.3 Dr. Reddy's Laboratories Quetiapine Fumarate Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Dr. Reddy's Laboratories Quetiapine Fumarate Tablets Product Portfolio
  42. 8.7.5 Dr. Reddy's Laboratories Recent Developments
  43. 8.8 AstraZeneca
  44. 8.8.1 AstraZeneca Company Information
  45. 8.8.2 AstraZeneca Business Overview
  46. 8.8.3 AstraZeneca Quetiapine Fumarate Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 AstraZeneca Quetiapine Fumarate Tablets Product Portfolio
  48. 8.8.5 AstraZeneca Recent Developments
  49. 8.9 Alkem Laboratories
  50. 8.9.1 Alkem Laboratories Company Information
  51. 8.9.2 Alkem Laboratories Business Overview
  52. 8.9.3 Alkem Laboratories Quetiapine Fumarate Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Alkem Laboratories Quetiapine Fumarate Tablets Product Portfolio
  54. 8.9.5 Alkem Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Quetiapine Fumarate Tablets Value Chain Analysis
  2. 9.1.1 Quetiapine Fumarate Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Quetiapine Fumarate Tablets Sales Mode & Process
  6. 9.2 Quetiapine Fumarate Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Quetiapine Fumarate Tablets Distributors
  9. 9.2.3 Quetiapine Fumarate Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst